Persistence of serum and saliva antibody responses to SARS-CoV-2 spike antigens in COVID-19 patients
Tóm tắt
Từ khóa
Tài liệu tham khảo
A. S. Iyera et al . Dynamics and significance of the antibody response to SARS-CoV-2 infection. MedRxiv https://www.medrxiv.org/content/10.1101/2020.07.18.20155374v1 (2020).
A. Wajnberg et al . SARS-CoV-2 infection induces robust neutralizing antibody responses that are 1 stable for at least three months. medRxiv https://www.medrxiv.org/content/10.1101/2020.07.14.20151126v1 (2020).
T. J. Ripperger et al . Detection prevalence and duration of humoral responses to SARS-CoV-2 under conditions of limited population exposure. medRxiv https://www.medrxiv.org/content/10.1101/2020.08.14.20174490v1 (2020).
L. B. Rodda et al. Functional SARS-CoV-2-specific immune memory persists after mild COVID-19. medRxiv (2020). 10.1101/2020.08.11.20171843
K. H. D. Crawford et al . Dynamics of neutralizing antibody titers in the months after SARS-CoV-2 infection. MedRxiv https://www.medrxiv.org/content/10.1101/2020.08.06.20169367v1 (2020).
J. Li et al. Virus-host interactome and proteomic survey of PMBCs from COVID-19 patients reveal potential virulence factors influencing SARS-CoV-2 pathogenesis. bioRxiv 2020.2003.2031.019216 (2020).
K. T. Abe et al . A simple protein-based SARS-CoV-2 surrogate neutralization assay. bioRxiv https://www.biorxiv.org/content/10.1101/2020.07.10.197913v1 (2020).
D. Sterlin et al . IgA dominates the early neutralizing antibody response to SARS-CoV-2. medRxiv https://www.medrxiv.org/content/10.1101/2020.06.10.20126532v1 (2020).
C. Cervia et al . Systemic and mucosal antibody secretion specific to SARS-CoV-2 during mild versus severe COVID-19. bioRxiv https://www.biorxiv.org/content/10.1101/2020.05.21.108308v1 (2020).
S. E. Faustini et al. Detection of antibodies to the SARS-CoV-2 spike glycoprotein in both serum and saliva enhances detection of infection. medRxiv (2020).
P. R. Randad et al. COVID-19 serology at population scale: SARS-CoV-2-specific antibody responses in saliva. medRxiv (2020).
Z. Wang et al . Enhanced SARS-CoV-2 Neutralization by Secretory IgA in vitro. bioRxiv https://www.biorxiv.org/content/10.1101/2020.09.09.288555v1 (2020).
S. Miersch et al . Synthetic antibodies neutralize SARS-CoV-2 infection of mammalian cells. bioRxiv https://www.biorxiv.org/content/10.1101/2020.06.05.137349v2 (2020).